.png)
About MigVax Ltd.
Mission and Values
​
MigVax was established in 2020 via a leading investment from OurCrowd, the crowdfunding venture investment platform, MigVax set out to modify a well-established coronavirus vaccine developed by Migal for the immunization of poultry, and to use its advanced methodologies to create its innovative oral subunit vaccine for the immunization of humans, starting with the COVID-19.
The COVID-19 vaccine project initiated upon a inter-disciplinary research team successful development of a vaccine against Infectious Bronchitis Virus (IBV), an avian (poultry) Coronavirus with high similarity to today’s human COVID-19 that uses the same infection mechanism.
Given the similarity, and following required genetic adjustments, the same vaccination concepts should apply. The inter-disciplinary research group is uniquely qualified to carry out this work. It carries several years of experience in vaccine development projects at MIGAL.
The Team
Management
​
David Zigdon President
​
Prof. Itamar Shalit SAB Clinical
​
Sigal Tal MD. VP Clinical & Regulatory
​
Ofira Carmi VP R&D
​
Ronald Ellis Ph.D. CTO
​
Galina Rodionov Quality Director
Einav Askenazi Project Manager
Researchers
​
Prof. Jacob Pitcovski Virology and Poultry Vaccination
​
Ehud Shahar Ph.D. Immunology
​
Itai Bloch Computational Chemistry
​
Itamar Yadid, Ph.D. Microbial Metabolic Pathways
Consultants
​
Rivka Zaibel QA/RA Consultant
​
Roni Pinkus Ph.D. Production Consultant
​
Migal Galilee Research Institute Ltd, an internationally-recognized multi-disciplinary applied research institute located in Israel’s northern Galilee. Migal was established in 1979, and today is addressing the world’s most pressing challenges by research in biotechnology, computer sciences, plant science, precision agriculture and environmental sciences, and food, nutrition and health. Recognized as a powerhouse of applied research, for forty years MIGAL has cooperated closely with industry leaders, innovative startups, and technological accelerators. MIGALs' employees include 90 PhDs and 190 researchers distributed across 44 research groups, operating as an innovative research ecosystem that encourages collaboration across scientific, industrial, agricultural, academic and technological specialties.
​
